Organometallics
ARTICLE
(Carom), 131.45 (Carom), 129.63 (Carom), 124.20 (Carom), 123.64
2.55ꢀ2.31 (4H, m, CHiPr), 1.20 (24H, d, CH3). 13C NMR (CDCl3,
ppm) (partial): δ = 144.39 (Cpy), 134.18 (Cpy), 133.18 (Cpy), 131.14
(Carom), 130.95 (2Carom), 130.79 (CPy), 128.70 (Carom), 127.56
(Carom), 127.40 (Carom), 126.82 (CHimi), 124.00 (Cpy), 123.62
(CHimi), 31.17 (NimCH2C), 28.67 (CHiPr), 23.71, 23.30 (CH3). EM
(m/z): 729 (Mþ).
[RuHCl(CO)(3a)] (3aRu). C24H29ClN4ORu (528.05). IR (KBr,
cmꢀ1): ν = 3050 (CHarom), 2052 (RuꢀH), 1939 (RuꢀCO), 1610,
1630 (CdC, CdN). UVꢀvis: λ (nm) = 258, 276, 334, 425. 1H NMR
(CDCl3, ppm): 7.85ꢀ7.67 (m, 2H, HPy), 7.64ꢀ7.50 (m, 1Himi),
7.48ꢀ7.35 (m, 2H, Harom), 7.34ꢀ7.28 (m, 1Himi), 7.22 (m, 1HPy),
6.12ꢀ5.99 (m, 2H, NimiCH2Cpy), 3.62ꢀ6.55 (m, 2H, CPyCH2Npyrr),
2.97ꢀ2.68 (m, 2H, CH2Npyrr), 2.50ꢀ2.45 (m, 2H, CH2Npyrr), 2.33
(3H, s, p-CH3), 2.00 (6H, s, o-CH3), 1.98 ꢀ1.77 (m, 4H, CH2-
CH2), ꢀ2.97 (s, 1H, HꢀRu). 13C NMR (CDCl3, ppm): δ = 191.18
(CO), 175.21 (CꢀRu), 158.70, 141.70, 134.67 (Cpy), 132.65 (Carom),
132.5 (Carom), 132.42 (Cpy), 130.28 (Carom), 128.97 (Carom), 128.82
(2Carom), 128.58 (CHimi), 123.98 (CHimi), 128.34 (Cpy), 65.60
(CpyCH2Npyrr), 60.23 [Npyrr(CH)2], 54.9 (NimiCH2CPy), 23.52
(CH2CH2Npyrr), 21.07 (p-CH3), 17.70 (o-CH3). EM (m/z): 493
([3aRu] ꢀ Cl).
(CHimi), 123.03 (Cpy), 122.91 (CHimi), 53.07 (NimiCH2C), 32.87
(CH2Br), 28.13 (CHiPr), 23.84, 23.78 (CH3). EM (m/z): 413 (Mþ
Br, 100).
ꢀ
1-(2,6-Diisopropylphenyl)-3-[(6-{[N-methyl-3-(triethoxysilyl)pro-
pan-1-amino]methyl}pyridin-2-yl)methyl]-1H-imidazol-3-ium Bro-
mide ([4b]Br). C35H56BrN4O3Si (687.33). IR (KBr, cmꢀ1): ν = 2963
(CHarom), 1591, 1574 (CdC, CdN). UVꢀvis (λ, nm): 288, 373. 1H
NMR (CDCl3, ppm): δ = 10.22 (1H, NCHN), 8.22 (1H, Himi), 7.82
(1H, Hpy), 7.71 (1H, m, Hpy), 7.53 (1H, Harom), 7.44 (1H, HPy), 7.30
(2H, m, Harom), 7.13 (1H, Himi), 6.18 (2H, s, NimiCH2Cpy), 4.19ꢀ4.00
[3H, m, OCH(CH3)2], 3.58ꢀ3.51 (2H, m, CPyCH2Npro), 2.36ꢀ
2.33 (2H, m, CH2CH2N), 2.31ꢀ2.25 (2H, m, CHiPr), 2.19ꢀ2.15
(3H, m, CH3N), 1.60ꢀ1.58 (2H, m, CH2CH2CH2), 1.19 (12H,
d, CH3), 1.16 (18H, d, CH3), 0.50 (2H, m, CH2Si). 13C NMR
(CDCl3, ppm): δ = 160.14 (Cpy), 151.81 (Cpy), 145.42 (Carom),
138.25 (NCHN), 132.00 (Carom), 138.23 (Cpy), 130.35 (Carom),
124.77 (2Carom), 123.94 (CHimi), 123.52 (CHimi), 123.29 (Cpy),
122,45 (Cpy), 64.98 (CHCH3), 63.81 (CpyCH2N), 60.91 (CH2N),
53.94 (NimiCH2Cpy), 42.24 (NCH3), 28.59 [CH(CH3)2], 25.50
[CH(CH3)2], 24.40 (CH3CH), 20.86 (CH2CH2CH2), 9.51 (CH2Si).
EM (m/z): 609 (Mþ ꢀ Br, 100).
[RuH(CO)(3a)] (3aRu-H). General procedure: To a suspension of
complex 3aRu (50 mg, 0.1 mmol) in THF (5 mL) was added KOtBu
(11.2 mg, 0.1 mmol) at ꢀ32 °C and the mixture was stirred at ꢀ32 °C
for 4 h and then filtered. The dark-red filtrate was concentrated under
vacuum to 0.5 ml, and 5 mL of pentane was added to precipitate a brown-
red solid, which was filtered and washed with pentane (3 ꢁ 2 mL) and
then dried under vacuum (40 mg, 89%). IR (KBr, cmꢀ1): ν = 3050
(CHarom), 1946 (CO, RuH), 1610, 1630 (CdC, CdN). UVꢀvis: λ
(nm) = 258, 276, 334, 425. 1H NMR (CDCl3, ppm): 7.85ꢀ7.55 (m, 3H,
HPy), 7.64ꢀ7.50 (m, 1Himi), 7.42ꢀ7.10 (m, 2H, Harom), 6.12ꢀ5.99 (m,
1Himi), 3.62ꢀ6.55 (m, 2H, CPyCH2Cpyrr), 2.53ꢀ2.45(m, 4H,
CH2Npyrr), 2.33 (3H, s, p-CH3), 2.00 (6H, s, o-CH3), 1.98ꢀ1.77 (m,
4H, CH2CH2), ꢀ2.50 (s, 1H, HꢀRu). 13C NMR (CDCl3, ppm):
143.21, 134.10, 133.67 (Cpy), 132.65 (Carom), 132.5 (Carom), 132.42
(Cpy), 130.28 (Carom), 128.97 (Carom), 128.82 (Carom), 128.42 (Carom),
126.03 (CHimi), 123.13 (CHimi), 122.5 (CPy), 60.43 (CH2Npyrr), 55.76
(CpyCH2Npyrr), 22.40 (CH2CH2Npyrr), 21.52 (p-CH3), 16.70 (o-CH3).
[Ru(H)2(CO)(3a)] (3aRu-H2). A suspension of complex 3aRu (50
mg, 0.1 mmol) in CDCl3 (5 mL) was stirred for 12 h under 5 atm of H2.
The solvent was evaporated and the solid was dried under vacuum. IR
(KBr, cmꢀ1): ν = 3050 (CHarom), 2050, 2006 (RuꢀH), 1936 (CO),
1610, 1630, (CdC, CdN). UVꢀvis: λ (nm) = 258, 276, 334, 425. 1H
NMR (CDCl3, ppm): 7.80ꢀ7.62 (m, 3H, HPy), 7.64ꢀ7.50 (m, 1Himi),
7.55ꢀ7.32 (m, 2H, Harom), 7.01ꢀ6.99 (m, 1Himi), 6.99ꢀ6.85 (m, 2H,
NimiCH2Cpy), 3.70ꢀ6.62 (m, 2H, CPyCH2Npyrr), 2.50ꢀ2.30 (m, 2H,
CH2CH2Npyrr), 2.33 (3H, s, p-CH3), 2.03 (6H, s, o-CH3), 1.81ꢀ1.77
(m, 4H, CH2CH2), ꢀ2.46 (s, 2H, HꢀRu). 13C NMR (CDCl3, ppm):
δ = 158.70, 141.70, 134.67 (Cpy), 132.65 (Carom), 132.5 (Carom), 132.42
(Cpy), 130.28 (Carom), 128.97 (Carom), 128.82 (Carom), 128.58 (CHimi),
127.45 (CHimi), 123.98 (CHimi), 123.34 (Cpy), 65.60 (NpyrrCH2), 60.23
(CpyCH2Npyrr), 54.9 (NimiCH2CPy), 23.51 (CH2CH2CH2), 21.11
(p-CH3), 17.70 (o-CH3).
Synthesis of Ruthenium Complexes. (a) A solution of [3a]Br
(1 mmol, 442 mg) or [3b]Br (1 mmol, 504 mg) and [RuHCl(CO)-
(PPh3)3]33 (0.1 mmol, 100 mg) in 2 mL of tetrahydrofuran (THF) was
stirred at reflux temperature under N2 atmosphere. After being stirred
overnight, the solution was filtered, the solvents were removed in vacuo,
and the residue was washed several times with diethyl ether. A solution
of KHMDS in toluene (0.5 M, 19.6 μL, 1.02 mmol) was added to Ru
complex in dry THF (5 mL). The resulting suspension was stirred for
2 h. The mixture was filtered and evaporated. Since the desired complex
was dissolved in CH2Cl2, ethyl ether was used to precipitate. The
complex was filtered off as a brown powder in 75% yield.
(b) The milder conditions of the transmetalation pathway make it an
attractive choice also for the synthesis of ruthenium complexes. The
imidazolium salt [3a]Br (2 mmol, 884 mg) or [3b]Br (2 mmol, 1.08 g)
was dissolved in 25 mL of dichloromethane and transferred into a
Schlenk vessel. Silver(I) oxide (1 mmol, 231 mg) was added, and the
mixture was stirred for 24 h at room temperature under an Ar atmo-
sphere. The unreacted Ag2O was filtered through a plug of Celite, and in
most cases the solution was directly applied for further synthetic steps.
The product can be isolated by removing the solvent in vacuo to give a
solid stable to oxygen and water. [RuHCl(CO)(PPh3)3] (1 mmol) was
taken up in 5 mL of dichloromethane and added to a solution of Ag
complex in 10 mL of CH2Cl2. A white precipitate (AgCl) formed, and
the mixture was stirred overnight at room temperature. After filtration in
air, the solvent was removed in vacuum to give a brown waxy substance.
The waxy substance was triturated with diethyl ether. The final
compound is stable in air.
[RuHCl(CO)(1a)] (1aRu). C32H34ClN5ORu (641.2). IR (KBr,
cmꢀ1): ν = 3050 (CHarom), 2051 (RuꢀH), 1937 (CO), 1610, 1630
1
(CdC, CdN). UVꢀvis: λ (nm) = 298. H NMR (CDCl3, ppm): δ
=7.89ꢀ6.99 (11H, m, Hpy, Harom, Himi), 6.13ꢀ6.02 (4H, m, NimCH2C),
2.27 (6H, s, p-CH3), 2 0.00 (12 H, s, o-CH3). 13C NMR (CDCl3, ppm)
(partial): δ = 144.25 (CPy), 134.39 (Cpy), 133.23 (Cpy), 133.18 (Carom),
132.15 (Carom), 131.93 (Carom), 131.85 (CPy), 128.56 (Carom), 128.40
(Carom), 128.11 (Carom), 125.00 (CHimi), 124.00 (Cpy), 123.62 (CHimi),
32.18 (NimCH2C), 26.38, 29.69 (p-CH3), 23.41, 21.15 (o-CH3).
EM (m/z): 669 ([1aRu] ꢀ Cl þ CH3COOH), 653 ([1aRu] ꢀ Cl þ
EtOH).
[RuH(CO)Cl(4b)] (4bRu). C36H57ClN4O3RuSi (774.35). IR (KBr,
cmꢀ1): ν = 3053 (CHarom), 2041 (RuꢀH), 1937 (CO), 1657, 1594
(CdC, CdN), 1107.1 (vs, SiꢀO). UVꢀvis (λ, nm): 288, 333, 370. 1H
NMR (CDCl3, ppm): δ = 7.79 (1H, Himi), 7.67ꢀ7.28 (6H, Hpy, Harom),
6.97 (1H, Himi), 5.49 (2H, s, NimiCH2Cpy), 4.20ꢀ3.99 [3H, m, OCH-
(CH3)2], 3.67ꢀ3.62 (2H, m, CPyCH2N), 2.44ꢀ2.39 (2H, m,
CH2CH2N), 2.38ꢀ2.36 (2H, m, CHiPr), 2.32ꢀ2.29 (3H, m, CH3N),
1.63ꢀ1.58 (2H, m, CH2CH2CH2), 1.17 (12H, d, CH3), 1.0 (18H,
d, CH3), 0.54ꢀ0.56 (2H, m, CH2Si). 13C NMR (CDCl3, ppm):
δ = 206.16 (CO), 186.54 (CꢀRu), 159.72 (Cpy), 145.39 (Cpy),
140.42 (Carom), 134.78, (Carom), 134.67 (Cpy), 131.96 (Carom),
[RuHCl(CO)(1b)] (1bRu). C38H46ClN5ORu (725.24). IR (KBr,
cmꢀ1): ν = 3050 (CHarom), 2049 (RuꢀH), 1942 (CO), 1610, 1630,
(CdC, CdN). UVꢀvis: λ (nm) = 290. 1H NMR (CDCl3, ppm): δ =
7.98ꢀ7.0 (13H, m, Hpy, Harom, Himi), 6.13ꢀ6.02 (4H, m, NimiCH2C),
2186
dx.doi.org/10.1021/om101179a |Organometallics 2011, 30, 2180–2188